Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen

被引：1

作者：

Reed, Daniel R. ^{[1
]}

Wooster, Margaux ^{[1
]}

Isom, Scott ^{[1
]}

Ellis, Leslie R. ^{[1
]}

Howard, Dianna S. ^{[1
]}

Manuel, Megan ^{[1
]}

Dralle, Sarah ^{[1
]}

Lyerly, Susan ^{[1
]}

Bhave, Rupali ^{[1
]}

Powell, Bayard L. ^{[1
]}

Pardee, Timothy S. ^{[1
]}

机构：

[1] Wake Forest Univ, Bowman Gray Sch Med, Sect Hematol & Med Oncol, Wake Forest Baptist Hlth Comprehens Canc Ctr, Med Ctr Blvd, Winston Salem, NC 27012 USA

来源：

ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 04期

关键词：

Acute Lymphoblastic Leukemia; Therapeutics; Chemotherapy Treatment Regimens; Real-World Outcomes; ELDERLY-PATIENTS; GROUP-B; SURVIVAL; THERAPY; CANCER; CONSOLIDATION; DEXAMETHASONE; IMPROVEMENT;

D O I：

10.1007/s00277-023-05141-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute lymphoblastic leukemia (ALL) is an aggressive bone marrow cancer with disparate outcomes. Data on patient outcomes in real world settings outside of clinical trials is limited. The current study reports on outcomes for 137 ALL patients who received an adult induction and consolidation regimen derived from the CALGB 10102 trial modified without alemtuzumab. Of the 137 patients, 32 were < 40 years old, 52 were between 40 and 59, and 53 were >= 60 years old. Overall, 109 (79.6%) patients achieved a complete remission (< 40: 96.1%, 40-59: 86.5%, and 62.3% >= 60 (p = 0.0002)). Progression free survival for the entire cohort was 13.5 months and by age was 19.8 months for less than 40, 23.4 months for 40 to 59 and 6.7 months for >= 60; p = 0.0002. Median survival was 22.1 months for the entire cohort (32.9 months for ages < 40, 26.6 months ages 40-59, 7.8 months >= 60, p < 0.001).

引用

页码：897 / 906

页数：10

共 29 条

[1] SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia [J].

Advani, Anjali S. ;

Moseley, Anna ;

O'Dwyer, Kristen M. ;

Wood, Brent L. ;

Fang, Min ;

Wieduwilt, Matthew J. ;

Aldoss, Ibrahim ;

Park, Jae H. ;

Klisovic, Rebecca B. ;

Baer, Maria R. ;

Stock, Wendy ;

Bhave, Rupali R. ;

Othus, Megan ;

Harvey, Richard C. ;

Willman, Cheryl L. ;

Litzow, Mark R. ;

Stone, Richard M. ;

Sharon, Elad ;

Erba, Harry P. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) :1574-+

[2] The treatment of adolescents and young adults with acute lymphoblastic leukemia [J].

Advani, Anjali S. ;

Hanna, Rabi .

LEUKEMIA & LYMPHOMA, 2020, 61 (01) :18-26

[3] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].

CHARLSON, ME ;

POMPEI, P ;

ALES, KL ;

MACKENZIE, CR .

JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383

[4] Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland [J].

Deeren, Dries ;

Balabanov, Stefan ;

Nickel, Katharina ;

Giannopoulou, Christina ;

Gonzalez-McQuire, Sebastian ;

Kutikova, Lucie ;

Bouwmeester, Walter ;

Spyridonidis, Alexandros .

LEUKEMIA RESEARCH, 2020, 91

[5] Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to the age of 60 years with Philadelphia chromosome-negative acute lymphoblastic leukemia [J].

Geyer, Mark B. ;

Ritchie, Ellen K. ;

Rao, Arati, V ;

Vemuri, Shreya ;

Flynn, Jessica ;

Hsu, Meier ;

Devlin, Sean M. ;

Roshal, Mikhail ;

Gao, Qi ;

Shukla, Madhulika ;

Salcedo, Jose M. ;

Maslak, Peter ;

Tallman, Martin S. ;

Douer, Dan ;

Park, Jae H. .

HAEMATOLOGICA, 2021, 106 (08) :2086-2094

[6] Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis [J].

Geyer, Mark B. ;

Hsu, Meier ;

Devlin, Sean M. ;

Tallman, Martin S. ;

Douer, Dan ;

Park, Jae H. .

BLOOD, 2017, 129 (13) :1878-1881

[7] Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL) [J].

Goekbuget, Nicola ;

Beck, Joachim ;

Brueggemann, Monika ;

Burmeister, Thomas ;

Buss, Eike C. ;

Frickhofen, Norbert ;

Huettmann, Andreas ;

Morgner, Anke ;

Reichle, Albrecht ;

Schmidt-Wolf, Ingo ;

Schwartz, Stefan ;

Serve, Hubert ;

Spriewald, Bernd M. ;

Starck, Michael ;

Stelljes, Matthias ;

Viardot, Andreas ;

Wendelin, Knut ;

Hoelzer, Dieter .

BLOOD, 2012, 120 (21)

[8] Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital [J].

Gupta, Rohan ;

Othman, Tamer ;

Uche, An ;

Amanam, Idoroenyi ;

Chen, Chen ;

Celles, Larissa ;

Lane, Gregorianna ;

Mei, Matthew ;

Aldoss, Ibrahim ;

Pullarkat, Vinod ;

Kim, Phyllis ;

Yeh, James .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06) :E320-E327

[9] Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial [J].

Huguet, Francoise ;

Chevret, Sylvie ;

Leguay, Thibaut ;

Thomas, Xavier ;

Boissel, Nicolas ;

Escoffre-Barbe, Martine ;

Chevallier, Patrice ;

Hunault, Mathilde ;

Vey, Norbert ;

Bonmati, Caroline ;

Lepretre, Stephane ;

Marolleau, Jean-Pierre ;

Pabst, Thomas ;

Rousselot, Philippe ;

Buzyn, Agnes ;

Cahn, Jean-Yves ;

Lheritier, Veronique ;

Bene, Marie C. ;

Asnafi, Vahid ;

Delabesse, Eric ;

Macintyre, Elizabeth ;

Chalandon, Yves ;

Ifrah, Norbert ;

Dombret, Herve .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) :2514-+

[10] Ponatinib and blinatumomab for Philadelphia chromosome- positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial [J].

Jabbour, Elias ;

Short, Nicholas J. ;

Jain, Nitin ;

Huang, Xuelin ;

Montalban-Bravo, Guillermo ;

Banerjee, Pinaki ;

Rezvani, Katayoun ;

Jiang, Xianli ;

Kim, Kun Hee ;

Kanagal-Shamanna, Rashmi ;

Khoury, Joseph D. ;

Patel, Keyur ;

Kadia, Tapan M. ;

Daver, Naval ;

Chien, Kelly ;

Alvarado, Yesid ;

Garcia-Manero, Guillermo ;

Issa, Ghayas C. ;

Haddad, Fadi G. ;

Kwari, Monica ;

Thankachan, Jennifer ;

Delumpa, Ricardo ;

Macaron, Walid ;

Garris, Rebecca ;

Konopleva, Marina ;

Ravandi, Farhad ;

Kantarjian, Hagop .

LANCET HAEMATOLOGY, 2023, 10 (01) :e24-e34

← 1 2 3 →